VA Medical Center - Lexington 596
Lexington, Kentucky, 40502, United States
NCT Number: NCT00821795
Volunteers are being invited to take part in a research study about insulin therapy of diabetes. They are being invited to take part in this research study because they have diabetes and have an illness requiring hospitalization. If they volunteer to take part in this study, they will be one of about 120 people to do so. The investigators hope to answer the following research questions:
* To show that insulin aspart protamine 70/30 mix taken twice daily is as good as insulin NPH/Reg 70/30 mix taken twice a day for treatment of diabetes after discharge from the hospital. * To show how safe the two medicines are (insulin aspart 70/30 mix vs. insulin NPH/Reg 70/30 mix) and how well they work for the treatment of diabetes when transitioning from inpatient therapy to outpatient care.
Looking for future studies?
Notify Me40 year and older
All sexes
Interventional
Phase 4
Lexington, Kentucky, 40502, United States
By doing this study, we hope to learn the optimal way to use insulin therapy to treat individuals during a hospitalization for an illness as well as during the recovery phase of the illness for twenty-four weeks after discharge from the hospital.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
injectable solution, subcutaneous,0.3-0.5 units/kg/day divided into twice per day dosage, 16 weeks duration
Other names: Novolin 70/30
injectable solution, subcutaneous, 0.3-0.5 units/kg/day divided into twice per day dosage, for 16 weeks
Other names: Novolog Mix 70/30
Time frame: 16 weeks
Hemoglobin A1c
Time frame: 2 weeks
mg/dl
Time frame: 16 weeks
Time frame: daily
Time frame: daily
Dennis G. Karounos, M.D.
Fed
Veterans Inpatient Insulin Study and Transition Algorithm: Efficacy of Insulin Analogs for Inpatient Glycemic Control and Transition to Outpatient Therapy
Acronym: VIISTA
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06362265
Diabetes Mellitus, Diabetes Mellitus, Type 2
Los Angeles, California, United States
View Trial DetailsNCT02227849
Diabetes Mellitus, Diabetes Mellitus, Type 2
Chūbu, Japan
View Trial DetailsNCT02622113
Diabetes Mellitus, Diabetes Mellitus, Type 2
Chugoku, Japan
View Trial DetailsNCT02220920
Diabetes Mellitus, Diabetes Mellitus, Type 2
Chugoku, Japan
View Trial Details